BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15095478)

  • 1. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
    Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
    J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis.
    Mikami S; Oya M; Mizuno R; Murai M; Mukai M; Okada Y
    Cancer Sci; 2006 Sep; 97(9):875-82. PubMed ID: 16856880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma.
    Thelen P; Hemmerlein B; Kugler A; Seiler T; Ozisik R; Kallerhoff M; Ringert RH
    Anticancer Res; 1999; 19(2C):1563-5. PubMed ID: 10365146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
    Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
    Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues.
    Liang Y; Li C; Guzman VM; Chang WW; Evinger AJ; Sao D; Woodward DF
    FEBS J; 2005 Feb; 272(3):791-9. PubMed ID: 15670159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression patterns of RGS transcripts in platelets.
    Kim SD; Sung HJ; Park SK; Kim TW; Park SC; Kim SK; Cho JY; Rhee MH
    Platelets; 2006 Nov; 17(7):493-7. PubMed ID: 17074726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
    Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
    Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
    Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
    Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K
    BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque.
    Li J; Adams LD; Wang X; Pabon L; Schwartz SM; Sane DC; Geary RL
    J Vasc Surg; 2004 Sep; 40(3):519-28. PubMed ID: 15337883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
    Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
    J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.